Phosphatonins and the regulation of phosphorus homeostasis

被引:148
作者
Berndt, TJ
Schiavi, S
Kumar, R
机构
[1] Mayo Coll Med, Mayo Clin, Dept Med, Div Nephrol & Hypertens, Rochester, MN 55905 USA
[2] Mayo Coll Med, Mayo Clin, Dept Biochem & Mol Biol, Div Nephrol & Hypertens, Rochester, MN 55905 USA
[3] Genzyme Corp, Receptor Ligand Therapeut, Framingham, MA USA
关键词
phosphate; secreted frizzled related protein 4; fibroblast growth factor 23; matrix extracellular phosphoglycoprotein; vitamin D;
D O I
10.1152/ajprenal.00072.2005
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Phosphate ions are critical for normal bone mineralization, and phosphate plays a vital role in a number of other biological processes such as signal transduction, nucleotide metabolism, and enzyme regulation. The study of rare disorders associated with renal phosphate wasting has resulted in the discovery of a number of proteins [ fibroblast growth factor 23 (FGF-23), secreted frizzled related protein 4 (sFRP-4), matrix extracellular phosphoglycoprotein, and FGF 7 (FGF-7)] that decrease renal sodium-dependent phosphate transport in vivo and in vitro. The "phosphatonins," FGF-23 and sFRP-4, also inhibit the synthesis of 1 alpha,25-dihydroxyvitamin D, leading to decreased intestinal phosphate absorption and further reduction in phosphate retention by the organism. In this review, we discuss the biological properties of these proteins, alterations in their concentrations in various clinical disorders, and their possible physiological role.
引用
收藏
页码:F1170 / F1182
页数:13
相关论文
共 139 条
[1]  
Aono Y, 2003, J BONE MINER RES, V18, pS16
[2]  
AURBACH GD, 1970, FED PROC, V29, P1179
[3]   Novel aspects in regulated expression of the renal type IIa Na/Pi-cotransporter [J].
Bacic, D ;
Wagner, CA ;
Hernando, N ;
Kaissling, B ;
Biber, J ;
Murer, H .
KIDNEY INTERNATIONAL, 2004, 66 :S5-S12
[4]   Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders [J].
Bai, XY ;
Miao, DS ;
Li, JR ;
Goltzman, D ;
Karaplis, AC .
ENDOCRINOLOGY, 2004, 145 (11) :5269-5279
[5]   The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency [J].
Bai, XY ;
Miao, DS ;
Goltzman, D ;
Karaplis, AC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (11) :9843-9849
[6]  
BAXTER LA, 1976, J BIOL CHEM, V251, P3158
[7]   FGF23 is processed by proprotein convertases but not by PHEX [J].
Beret-Pagès, A ;
Lorenz-Depiereux, B ;
Zischka, H ;
White, KE ;
Econs, MJ ;
Strom, TM .
BONE, 2004, 35 (02) :455-462
[8]   Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent [J].
Berndt, T ;
Craig, TA ;
Bowe, AE ;
Vassiliadis, J ;
Reczek, D ;
Finnegan, R ;
De Beur, SMJ ;
Schiavi, SC ;
Kumar, R .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (05) :785-794
[9]  
Berndt T., 1992, KIDNEY PHYSL PATHOPH, P2511
[10]  
BIBER J, 1994, RENAL PHYSIOL BIOCH, V17, P212